DJ bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne
bonyf NV / Key word(s): Product Launch/Patent bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne 13-March-2025 / 13:45 CET/CEST =---------------------------------------------------------------------------------------------------------------------- bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne Knokke-Heist (Belgium), 13 March 2025, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), a leader in dental consumer goods and professional dental consumables, presents PerioTabs® and Periocream at the future exhibition in Cologne from 25-29 March 2025 at the IDS, leading global trade fair for the dental community. PerioTabs®-Periocream's participation in this premier event highlights its potential to revolutionize dental care practices globally. Visit bonyf at the IDS Hall 5.2, Booth 131. Products Overview: 1. PerioTabs®: Designed for daily at-home use, PerioTabs® is an effervescent tablet that dissolves in water to create a brushing solution. This advanced formulation targets and eliminates oral biofilm accumulation on gums, teeth, and dental implants, effectively reducing the clinical signs of gingivitis, periodontitis, peri-mucositis and peri-implantitis. 2. Periocream: Intended for professional application, Periocream is used by dental professionals after scaling and root planning to form a protective barrier over the gum line. This barrier aids in reducing bleeding, alleviating pain, and promoting faster healing, enhancing patient comfort. Showcasing at IDS 2025 (25/03 till 29/03) - Hall 5.2, Booth B 131: The International Dental Show (IDS) is the leading global trade fair for the dental community, attracting over 2,000 exhibitors from 60 countries and more than 120,000 visitors from 162 countries. PerioTabs®-Periocream's participation in this premier event highlights its potential to revolutionize dental care practices globally. Attendees are invited to visit the PerioTabs®-Periocream booth to experience firsthand demonstrations, gain insights into the cutting-edge science behind the products, and discuss potential collaborations. With its patented technology and dual-action approach, PerioTabs®-Periocream is poised to set new standards in oral healthcare, offering both professionals and consumers effective tools in the fight against periodontal diseases. bonyf is a leading provider of dental consumer goods and professional dental consumables, with a strong presence across the world. The company is currently listed on Euronext Paris and is dedicated to advancing dental care through innovation and high-quality products. For more information, visit bonyf.com or contact investor@bonyf.com. bonyf's strengths -- Products with patented formulations -- Produced in Switzerland compliant with stringent international quality regulations -- Proven clinical efficacy -- Commercial presence in 37 countries -- Prospects for solid growth and rapid profitability -- A fast-growing oral and dental care market About bonyf Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. bonyf is a forward-thinking company committed to revolutionizing oral care through innovation and research. With a focus on quality and efficacy, bonyf develops cutting-edge products designed to enhance the well-being of individuals worldwide. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market. For more information about bonyf and its innovative oral care products, please visit www.bonyf.com. bonyf Jean-Pierre Bogaert investor@bonyf.com
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Financial Wire News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
Language: English
Issuer: bonyf NV
Kalvekeetdijk 179, box 105
8300 Knokke-Heist
Belgium
Phone: +41 79 412 42 79
E-mail: president@bonyf.com
Internet: www.bonyf.com
ISIN: BE6333353298
EQS News ID: 2100218
End of Announcement - EQS News Service
=------------------------------------------------------------------------------------
2100218 13-March-2025 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=0d643b50e746065786c1be54c09374ce
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=c1e984519a16cbde23c846d5aed7366e
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=6f19d539bb43b1b61efd4422accd87ca
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2100218&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face
(END) Dow Jones Newswires
March 13, 2025 08:46 ET (12:46 GMT)
